From Concept to Clinical Practice: A Detailed Review of Total Artificial Heart Devices

Year : 2025 | Volume : 15 | Issue : 01 | Page : 1 4
    By

    D.V Surya Prakash,

  • Parnika Vashist,

  • Palak Priya,

  • Neha Singh,

  • Nitika Vats,

  1. Assistant Professor, Department of Biotechnology, Meerut Institute of Engineering and Technology, Uttar Pradesh, India
  2. Student, Department of Biotechnology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh, India
  3. Student, Department of Biotechnology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh, India
  4. Assistant Professor, Department of Biotechnology, Meerut Institute of Engineering and Technology, Uttar Pradesh, India
  5. Assistant Professor, Department of Biotechnology, Meerut Institute of Engineering and Technology, Uttar Pradesh, India

Abstract

Total artificial heart (TAH) devices are mechanical systems designed to take over the role of a failing heart in patients with severe heart failure. Unlike ventricular assistance devices (VADs), which only support one side of the heart, TAHs replace both ventricles, providing a possible solution for patients who cannot receive a heart transplant. Over time, TAH technology has evolved with a focus on improving biocompatibility, reducing complications related to the device, and improving patient outcomes. However, significant challenges remain, such as long-term durability, infection risks, and the need for ongoing anticoagulation. Despite these obstacles, TAHs have become a vital option for patients awaiting heart transplants or as a temporary solution to recovery. This paper examines the history, technological progress, clinical uses, and prospects of TAH devices, highlighting their potential to transform heart failure treatment in the future.

Keywords: Artificial, heart, treatment, ventricle, device

[This article belongs to Research and Reviews : A Journal of Life Sciences ]

How to cite this article:
D.V Surya Prakash, Parnika Vashist, Palak Priya, Neha Singh, Nitika Vats. From Concept to Clinical Practice: A Detailed Review of Total Artificial Heart Devices. Research and Reviews : A Journal of Life Sciences. 2025; 15(01):1-4.
How to cite this URL:
D.V Surya Prakash, Parnika Vashist, Palak Priya, Neha Singh, Nitika Vats. From Concept to Clinical Practice: A Detailed Review of Total Artificial Heart Devices. Research and Reviews : A Journal of Life Sciences. 2025; 15(01):1-4. Available from: https://journals.stmjournals.com/rrjols/article=2025/view=193215


References

  1. Fumoto H, Horvath DJ, Rao S, et al. In vivo acute performance of the cleveland clinic self-regulating, continuous-flow total artificial heart. J Heart Lung Transplant. 2010;29(1):21–26.
  2. Dowling RD, Gray LA, Jr, Etoch SW, et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg. 2004;127(1):131–141.
  3. Demondion P, Fournel L, Niculescu M, et al. The challenge of home discharge with a total artificial heart: the La Pitie Salpetriere experience. Eur J Cardiothorac Surg. 2013;44(5):843–848.
  4. Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report–2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33(10):996–1008.
  5. Thanavaro KL, Tang DG, Cooke RH, et al. Characteristics and survival of patients with the total artificial heart implanted for indications other than biventricular failure. J Heart Lung Transplant. 2013;32(4):S231.
  6. Copeland JG, Smith RG, Arabia FA, et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351(9):859–867.
  7. Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139(5):1316–1324.
  8. Drakos SG, Janicki L, Horne BD, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol. 2010;105(7):1030–1035.
  9. Kirsch M, Mazzucotelli JP, Roussel JC, et al. Survival after biventricular mechanical circulatory support: does the type of device matter? J Heart Lung Transplant. 2012;31(5):501–508.
  10. Ryan TD, Jefferies JL, Zafar F, et al. The evolving role of the total artificial heart in the management of end-stage congenital heart disease and adolescents. ASAIO J. 2015;61(1):8–14.
  11. Szefner J. Control and treatment of hemostasis in cardiovascular surgery. The experience of La Pitié Hospital with patients on total artificial heart. Int J Artif Organs. 1995;18(10):633–648.
  12. DeVries WC. Surgical technique for implantation of the Jarvik-7-100 total artificial heart. JAMA. 1988;259(6):875–880.
  13. Copeland J, Copeland H, Nolan P, et al. Results with an anticoagulation protocol in 99 SynCardia total artificial heart recipients. ASAIO J. 2013;59(3):216–220.
  14. Mankad AK, Tang DG, Clark WB, et al. Persistent anemia after implantation of the total artificial heart. J Card Fail. 2012;18(6):433–438.
  15. Copeland JG, Smith RG, Arabia FA, et al. Total artificial heart bridge to transplantation: a 9-year experience with 62 patients. J Heart Lung Transplant. 2004;23(7):823–831.
  16. Copeland JG, Copeland H, Gustafson M, et al. Experience with more than 100 total artificial heart implants. J Thorac Cardiovasc Surg. 2012;143(3):727–734.
  17. Delgado R, 3rd, Wadia Y, Kar B, et al. Role of B-type natriuretic peptide and effect of nesiritide after total cardiac replacement with the AbioCor total artificial heart. J Heart Lung Transplant. 2005;24(8):1166–1170.
  18. Levinson MM, Copeland JG, Smith RG, et al. Indexes of hemolysis in human recipients of the Jarvik-7 total artificial heart: a cooperative report of fifteen patients. J Heart Transplant. 1986;5(3):236–248.
Regular Issue Subscription Review Article
Volume 15
Issue 01
Received 13/01/2024
Accepted 26/12/2024
Published 09/01/2025
431

Login


My IP

PlumX Metrics